Literature DB >> 97669

Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization.

R Levy, J Dilley.   

Abstract

B leukemia cells from four different patients were hybridized with a mouse myeloma cell line with polyethylene glycol as a fusing agent. The original leukemia cells all expressed immunoglobulin on their surface, but failed to secrete it. Over 200 different human-mouse somatic cell hybrids were obtained; 57% of them secreted human immunoglobulin in large amounts. Human immunoglobulin secretion can be a stable property of these hybrid cells over months of continuous culture. In each case the human immunoglobulin secreted was restricted to the light chain type expressed by the parental B leukemia cell. In addition, these hybrid cells secreted the original mouse myeloma protein and a variety of mixed human-mouse immunoglobulin molecules.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97669      PMCID: PMC392563          DOI: 10.1073/pnas.75.5.2411

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Immunoglobulin production by a human-mouse somatic cell hybrid.

Authors:  J Schwaber
Journal:  Exp Cell Res       Date:  1975-07       Impact factor: 3.905

3.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

4.  The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.

Authors:  R Levy; E Hurwitz; R Maron; R Arnon; M Sela
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

Review 5.  The lymphoid system. Its normal architecture and the potential for understanding the system through the study of lymphoproliferative diseases.

Authors:  I L Weissman; R Warnke; E C Butcher; R Rouse; R Levy
Journal:  Hum Pathol       Date:  1978-01       Impact factor: 3.466

6.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

7.  Letter: Fusion of two immunoglobulin-producing myeloma cells.

Authors:  R G Cotton; C Milstein
Journal:  Nature       Date:  1973-07-06       Impact factor: 49.962

8.  A study of malignant lymphomas using light and ultramicroscopic, cytochemical and immunologic technics: correlation with clinical features.

Authors:  D A Filippa; P H Lieberman; R A Erlandson; B Koziner; F P Siegal; A Turnbull; A Zimring; R A Good
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

9.  Novel idiotypic and antigen-binding characteristics in two anti-dinitrophenyl monoclonal antibodies.

Authors:  N H Sigal
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  The monoclonality of human B-cell lymphomas.

Authors:  R Levy; R Warnke; R F Dorfman; J Haimovich
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more
  31 in total

1.  Assembly and secretion of pentameric IgM in a fusion between a nonsecreting B cell lymphoma and an IgG-secreting plasmacytoma.

Authors:  W C Raschke; E L Mather; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines.

Authors:  Kamran Kafi; David J Betting; Reiko E Yamada; Michael Bacica; Kristopher K Steward; John M Timmerman
Journal:  Mol Immunol       Date:  2008-11-28       Impact factor: 4.407

Review 3.  The human immune response to red blood cell antigens as revealed by repertoire cloning.

Authors:  D L Siegel
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  Extinction of expression of immunoglobulin genes in myeloma X fibroblast somatic cell hybrids.

Authors:  A Greenberg; R Ber; Z Kra-Oz; R Laskov
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 5.  A brief personal history of cancer immunotherapy at Stanford: if these walls could talk….

Authors:  Ron Levy
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Cloning and sequence determination of a human rheumatoid factor light-chain gene.

Authors:  F R Jirik; J Sorge; S Fong; J G Heitzmann; J G Curd; P P Chen; R Goldfien; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Induction of amplified synthesis and secretion of IgM by fusion of murine 'b lymphoma with myeloma cells.

Authors:  R Laskov; K J Kim; R Asofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

Review 8.  Immunotherapy for lymphomas.

Authors:  John M Timmerman
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

Review 9.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

10.  Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.

Authors:  D Kozbor; A E Lagarde; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.